Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New guidelines for adjuvant systemic therapy in breast cancer deemed acceptable
February 2nd, 2006
The cost-effectiveness of the new guidelines for adjuvant systemic therapy for patients with primary breast cancer was deemed acceptable. According to a report from the Netherlands, "In this study, the potential impact of a new national guideline for adjuvant systemic therapy in breast cancer (introduced in the Netherlands in 1998) was assessed, as well as the modifications of this guideline, issued in 2001. Both the change in total number of patients eligible for adjuvant therapy, as well as the cost-effectiveness of the changed clinical management of these patients were analyzed." "Percentages of patients who would be eligible for adjuvant therapy...
Source: Women's Health Weekly (2006-02-02)
|
